869088-31-3

Basic information

• Product Name: (4-chloro-2-ethoxyphenyl)methanol
• Synonyms: (4-chloro-2-ethoxyphenyl)methanol
• CAS NO: 869088-31-3
• Molecular Weight: 186.638
• Mol File: 869088-31-3.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: (4-chloro-2-ethoxyphenyl)methanol(CAS DataBase Reference)
• NIST Chemistry Reference: (4-chloro-2-ethoxyphenyl)methanol(869088-31-3)
• EPA Substance Registry System: (4-chloro-2-ethoxyphenyl)methanol(869088-31-3)

Safety Data

• Hazardous Substances Data: 869088-31-3(Hazardous Substances Data)

Upstream product

• 472809-12-4 4-chloro-2-ethoxybenzoic acid ethyl ester 

Downstream Products

• 1613413-01-6 2-[5-[(4-chloro-2-ethoxyphenyl)methoxy]pyrazol-1-yl]pyridine-4-carbonitrile 
• 105188-34-9 4-chloro-(1-chloromethyl)-2-ethoxybenzene 
• 869088-32-4 4-chloro-2-ethoxybenzaldehyde 

Relevant articles and documents

HISTONE DEMETHYLASE INHIBITORS

Provided herein are substituted pyrazolylpyridine, pyrazolylpyridazine, and pyrazolylpyrimidine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.

ARYLALKANOIC ACID DERIVATIVE

A compound represented by the general formula (I): [wherein Ar represents an optionally substituted aromatic ring; Xa, Xc, Ya, Yc, Z1, and Z2 each represents a bond, O, S, -CO-, -CS-, -CR3(OR4)-, -NR5-, -SO-, -SO2-, -CONR6-, or -NR6CO- (R3, R4, R5, and R6 are as defined in the description); Xb and Yb each represents a bond or a C1-20 divalent hydrocarbon group; R1 represents an optionally substituted hydrocarbon group; ring A represents an aromatic ring (other than benzimidazole) which may be further substituted; n is an integer of 1-8; ring B represents an aromatic ring (other than oxazole) which may be further substituted; W represents a C1-20 divalent saturated hydrocarbon group; and R2 represents -OR8 or -NR9R10 (R8, R9, and R10 are as defined in the description)] or a salt of the compound. It is useful as a preventive/therapeutic agent for diabetes, etc.

Novel compounds

The present invention provides compounds of Formula I wherein R1, R2, R3, and n have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment